P
US12458345B2ActiveUtilityPatentIndex 59

Method for implementing a staple system

Assignee: CILAG GMBH INTPriority: May 10, 2021Filed: Apr 12, 2022Granted: Nov 4, 2025
Est. expiryMay 10, 2041(~14.8 yrs left)· nominal 20-yr term from priority
Inventors:RECTOR JASON MVENDELY MICHAEL JSHELTON IV FREDERICK EHARRIS JASON LMCGHEE RYAN WROLL BENJAMIN APATHAK SHASHI SJONES SHANNON LBECK STEFAN
A61L 2103/15A61L 2103/23A61L 31/16A61B 2017/07264A61B 2017/00845A61B 17/07207A61L 31/048A61L 31/028A61B 2017/00119A61B 2017/00084A61B 2090/0807A61B 2050/3004A61B 50/3001A61B 2017/07285A61B 2017/07278A61B 2017/07257A61B 2017/0688A61B 2017/00022A61B 17/105A61B 90/98A61L 31/10A61B 17/064A61L 31/148A61L 31/042A61L 31/022A61B 2017/07235A61B 17/0686A61B 2017/07228A61B 2017/07271A61B 2017/00004A61B 17/072A61B 50/20A61N 2005/1098A61N 2005/1087A61N 5/1027A61L 2/232A61L 2/16A61L 2/02A61L 2400/10A61L 2300/252A61L 31/08A61L 2420/04A61L 31/082A61B 2050/0065A61B 2017/00938A61B 2017/00889A61B 2017/00849A61B 90/92A61B 2017/00221A61B 2017/00477A61B 90/94A61B 2090/0809A61B 50/33A61B 2050/314A61B 2090/038A61B 2017/00115A61B 2017/00398A61B 2017/00893A61B 2017/0053A61B 2017/00853A61B 17/07292A61B 2017/00017A61B 2017/00526A61B 17/0644
59
PatentIndex Score
0
Cited by
663
References
19
Claims

Abstract

A method of preparing a staple cartridge includes forming first staples with a first alloy, and forming second staples with a second alloy that is different than the first alloy. The method includes positioning the first staples into staple cavities of a first row of staple cavities of the staple cartridge, the first row of staple cavities being a first distance from an elongate slot of the staple cartridge, and positioning the second staples into staple cavities of a second row of staple cavities, the second row of staple cavities being a second distance from the elongate slot of the staple cartridge. The second distance is greater than the first distance. The first staples are configured to degrade at a first rate in a tissue environment, and the second staples are configured to degrade at a second rate that is different than the first rate.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of preparing a staple cartridge, the method comprising:
 forming first staples with a first alloy, wherein the first staples comprise a material configured to deliver radiotherapy into a tissue environment within a patient, the material comprising a doped alloy comprising an alpha particle emitter;   forming second staples with a second alloy that is different than the first alloy;   positioning the first staples into staple cavities of a first row of staple cavities of the staple cartridge, wherein the first row of staple cavities is a first distance from an elongate slot of the staple cartridge; and   positioning the second staples into staple cavities of a second row of staple cavities, wherein the second row of staple cavities is a second distance from the elongate slot of the staple cartridge, wherein the second distance is greater than the first distance;   wherein the first staples are configured to degrade at a first rate in the tissue environment within the patient, and wherein the second staples are configured to degrade at a second rate in the tissue environment that is different than the first rate.   
     
     
         2 . The method of  claim 1 , wherein the second rate is faster than the first rate. 
     
     
         3 . The method of  claim 1 , further comprising:
 forming third staples with a third alloy that is different than the first alloy and the second alloy; and   positioning the third staples into staple cavities of a third row of staple cavities wherein the third row of staple cavities is a third distance from the elongate slot of the staple cartridge, wherein the third distance is greater than the second distance;   wherein the third staples are configured to degrade at a third rate in the tissue environment that is different than the second rate.   
     
     
         4 . The method of  claim 3 , wherein the third rate is faster than the second rate. 
     
     
         5 . The method of  claim 1 , further comprising coupling an implantable adjunct to a deck of the staple cartridge. 
     
     
         6 . The method of  claim 5 , wherein the implantable adjunct is comprised of an absorbable polymer. 
     
     
         7 . The method of  claim 1 , wherein:
 the first alloy is selected from the group consisting of a magnesium-based alloy, a zinc-based alloy, and an iron-based alloy; and   the second alloy is selected from the group consisting of a magnesium-based alloy, a zinc-based alloy, and an iron-based alloy.   
     
     
         8 . The method of  claim 1 , wherein the first staples further comprise a radiosensitizer. 
     
     
         9 . The method of  claim 8 , wherein the radiosensitizer comprises hafnium oxide. 
     
     
         10 . A method of preparing a staple cartridge, the method comprising:
 forming first staples with a first alloy, wherein the first staples comprise a material configured to deliver a treatment therapy into a tissue environment within a patient, the material comprising a doped alloy comprising an alpha particle emitter;   forming second staples with a second alloy that is different than the first alloy;   positioning the first staples into staple cavities of a first row of staple cavities of the staple cartridge, wherein the first row of staple cavities is a first distance from an elongate slot of the staple cartridge; and   positioning the second staples into staple cavities of a second row of staple cavities, wherein the second row of staple cavities is a second distance from the elongate slot of the staple cartridge, wherein the second distance is greater than the first distance.   
     
     
         11 . The method of  claim 10 , further comprising coupling an implantable adjunct to a deck of the staple cartridge. 
     
     
         12 . The method of  claim 10 , further comprising:
 coating the first staples with a first coating; and   coating the second staples with a second coating that is different than the first coating.   
     
     
         13 . A method of preparing a staple cartridge, the method comprising:
 forming first staples with a first alloy, wherein the first staples comprise a material configured to deliver radiotherapy into a tissue environment within a patient, the material comprising a doped alloy comprising an alpha particle emitter;   coating the first staples with a first coating;   forming second staples with a second alloy that is different than the first alloy;   coating the second staples with a second coating that is the same as the first coating;   positioning the first staples into staple cavities of a first row of staple cavities of the staple cartridge, wherein the first row of staple cavities is a first distance from an elongate slot of the staple cartridge; and   positioning the second staples into staple cavities of a second row of staple cavities, wherein the second row of staple cavities is a second distance from the elongate slot of the staple cartridge, wherein the second distance is greater than the first distance;   wherein the first staples are configured to degrade at a first rate in the tissue environment within the patient, and wherein the second staples are configured to degrade at a second rate in the tissue environment that is different than the first rate.   
     
     
         14 . The method of  claim 13 , wherein the second rate is faster than the first rate. 
     
     
         15 . The method of  claim 13 , further comprising:
 forming third staples with a third alloy that is different than the first alloy and the second alloy;   coating the third staples with a third coating that is the same as the first coating;   positioning the third staples into staple cavities of a third row of staple cavities   wherein the third row of staple cavities is a third distance from the elongate slot of the staple cartridge, wherein the third distance is greater than the second distance;   wherein the third staples are configured to degrade at a third rate in the tissue environment that is different than the second rate.   
     
     
         16 . The method of  claim 15 , wherein the third rate is faster than the second rate. 
     
     
         17 . The method of  claim 13 , further comprising coupling an implantable adjunct to a deck of the staple cartridge. 
     
     
         18 . The method of  claim 17 , wherein the implantable adjunct is comprised of an absorbable polymer. 
     
     
         19 . The method of  claim 13 , wherein:
 the first alloy is selected from the group consisting of a magnesium-based alloy, a zinc-based alloy, and an iron-based alloy; and   the second alloy is selected from the group consisting of a magnesium-based alloy, a zinc-based alloy, and an iron-based alloy.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.